✦ LIBER ✦

PEG IFN-α-2a beats conventional therapy in hep C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEG IFN-α-2a beats conventional therapy

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 144 KB

PEG IFN-α-2b + weight-based ribavirin be

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 140 KB

PEG IFN-α-2b + weight-based ribavirin be

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 137 KB

PEG IFN-α-2a improves QOL in hepatitis C

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 118 KB

PEG IFN-α-2b superior to IFN-α-2b in chr

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Nearly one-quarter market share for hep

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 131 KB